相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing
Moeko Tsutsuura et al.
BMC INFECTIOUS DISEASES (2021)
Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2021)
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2020)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 Study
Jiajun Liu et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis
Doaa M. Aljefri et al.
CLINICAL INFECTIOUS DISEASES (2019)
Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model
Sean N. Avedissian et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Pharmacokinetic/Pharmacodynamic Determinants of Vancomycin Efficacy in Enterococcal Bacteremia
Muhammed Taufiq Bin Jumah et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Establishment of an AUC0-24 Threshold for Nephrotoxicity Is a Step towards Individualized Vancomycin Dosing for Methicillin-Resistant Staphylococcus aureus Bacteremia
R. Chavada et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
Michael N. Neely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
S. J. van Hal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia
Yosuke Suzuki et al.
CHEMOTHERAPY (2012)
Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2009)
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Ravindra L. Mehta et al.
CRITICAL CARE (2007)
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
R Bellomo et al.
CRITICAL CARE (2004)
分享论文
